Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederick S Varn

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Nature|May 6, 2026
Male sex hormone loss aids brain tumour growthFrederick S Varn
Oncoimmunology|December 15, 2018
A B cell-derived gene expression signature associates with an immunologically active tumor microenvironment and response to immune checkpoint blockade therapyFrederick S Varn, Yue Wang, Chao Cheng
Scientific Reports|November 25, 2015
Systematic analysis of hematopoietic gene expression profiles for prognostic prediction in acute myeloid leukemiaFrederick S Varn, Erik H Andrews, Chao Cheng
Expert Opinion on Drug Discovery|October 1, 2016
In silico frameworks for systematic pre-clinical screening of potential anti-leukemia therapeuticsMatthew H Ung, Frederick S Varn, Chao Cheng
Molecular Cancer Research : MCR|June 3, 2015
E2F4 Program Is Predictive of Progression and Intravesical Immunotherapy Efficacy in Bladder CancerChao Cheng, Frederick S Varn, Carmen J Marsit
Cancer Research|September 27, 2018
Genomic Characterization of Six Virus-Associated Cancers Identifies Changes in the Tumor Immune Microenvironment and Altered Genetic ProgramsFrederick S Varn, Evelien Schaafsma, Yue Wang, et al.
Plos Computational Biology|May 22, 2015
Regulators associated with clinical outcomes revealed by DNA methylation data in breast cancerMatthew H Ung, Frederick S Varn, Shaoke Lou, et al.
Oncoimmunology|June 7, 2018
Computational immune profiling in lung adenocarcinoma reveals reproducible prognostic associations with implications for immunotherapyFrederick S Varn, Laura J Tafe, Christopher I Amos, et al.
Oncotarget|September 3, 2016
Application of pharmacologically induced transcriptomic profiles to interrogate PI3K-Akt-mTOR pathway activity associated with cancer patient prognosisMatthew H Ung, George L Wang, Frederick S Varn, et al.
Nature Communications|January 5, 2016
Integrative analysis of breast cancer reveals prognostic haematopoietic activity and patient-specific immune response profilesFrederick S Varn, Erik H Andrews, David W Mullins, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Nature|May 6, 2026
Male sex hormone loss aids brain tumour growthFrederick S Varn
Oncoimmunology|December 15, 2018
A B cell-derived gene expression signature associates with an immunologically active tumor microenvironment and response to immune checkpoint blockade therapyFrederick S Varn, Yue Wang, Chao Cheng
Scientific Reports|November 25, 2015
Systematic analysis of hematopoietic gene expression profiles for prognostic prediction in acute myeloid leukemiaFrederick S Varn, Erik H Andrews, Chao Cheng
Expert Opinion on Drug Discovery|October 1, 2016
In silico frameworks for systematic pre-clinical screening of potential anti-leukemia therapeuticsMatthew H Ung, Frederick S Varn, Chao Cheng
Molecular Cancer Research : MCR|June 3, 2015
E2F4 Program Is Predictive of Progression and Intravesical Immunotherapy Efficacy in Bladder CancerChao Cheng, Frederick S Varn, Carmen J Marsit
Cancer Research|September 27, 2018
Genomic Characterization of Six Virus-Associated Cancers Identifies Changes in the Tumor Immune Microenvironment and Altered Genetic ProgramsFrederick S Varn, Evelien Schaafsma, Yue Wang, et al.
Plos Computational Biology|May 22, 2015
Regulators associated with clinical outcomes revealed by DNA methylation data in breast cancerMatthew H Ung, Frederick S Varn, Shaoke Lou, et al.
Oncoimmunology|June 7, 2018
Computational immune profiling in lung adenocarcinoma reveals reproducible prognostic associations with implications for immunotherapyFrederick S Varn, Laura J Tafe, Christopher I Amos, et al.
Oncotarget|September 3, 2016
Application of pharmacologically induced transcriptomic profiles to interrogate PI3K-Akt-mTOR pathway activity associated with cancer patient prognosisMatthew H Ung, George L Wang, Frederick S Varn, et al.
Nature Communications|January 5, 2016
Integrative analysis of breast cancer reveals prognostic haematopoietic activity and patient-specific immune response profilesFrederick S Varn, Erik H Andrews, David W Mullins, et al.
Pageof 5